We are currently enrolling participants for the following clinical trials:

  • Dermal filler study
  • Rosacea study
  • Botox forehead study

Ongoing Studies

The following clinical trials are currently in process:

  • Underarm sweating study
  • Rosacea study
  • Toenail fungus study
  • Acne study
  • Botox forehead study
  • Midface filler study

Upcoming Studies

  • Actinic Keratosis (pre-cancer) study
  • Midface filler study
  • Lip filler study


Completed Clinical Trials:

  • A split face, double-blind, randomized clinical trial of the effects of RV3718A using two applications per day to the half face for 3 months followed by 2 applications per day to the whole face for 3 months.
  • The P.U.M.P Study: Patients using MICRO properly; an open-label, community based, phase IV study to assess facial acne improvement with the use of Retin-A Micro (Tretinoin gel) microsphere, 0.04% or 0.1% in a pump dispenser
  • A Phase III, randomized, placebo-controlled, multi-center, double-blind study of the safety and duration of efficacy of Reloxin (Botulinum Type A Toxin) in correction of moderate to severe glabellar lines (and including a sub-study to detect any treatment-related QT interval changes)
  • A multi-center, Phase 3, randomized, double-blind, clinical trial to compare the safety and efficacy Clin-RA Gel vs. Clindamycin Phosphate 1.2% Gel in the treatment of acne vulgaris
  • Protocol C-05-16 Treatment of the upper arms using the ThermaCool System
  • To demonstrate the ability of Onion extract cream (Mederma Cream plus SPF) to improve the cosmetic appearance of post laser scar removal
  • Open-label, randomized, split-face study to evaluate the efficacy, safety and subject satisfaction of pain management during and after Restylane dermal filler injections for the correction of nasolabial folds
  • A phase ¾ multi-center, open-label extension study to assess the long-term safety of repeat administrations of Reloxin in the treatment of glabellar lines
  • A prospective, randomized, double-blind, placebo controlled, multicenter trial to investigate the efficacy and safety of NT 201, free of complexing proteins, in the treatment of glabellar frown lines


Read 6983 times Last modified on Friday, 20 April 2012 20:07
You are here: Home Research

Aventura, Bal Harbour, Coconut Grove, Coral Gables, Doral, Golden Beach, Hallandale, Miami Beach, Miami, North Bay Village,  North Miami, North Miami Beach, South Beach, Sunny Isles Beach

2925 Aventura Blvd. | Suite 205 | Aventura, FL 33180 |  305.933.6716